APA-referens (7:e uppl.)

Rong, Z., Li, L., Fei, F., Luo, L., & Qu, Y. (2025). Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer. BMC.

Chicago-referens (17:e uppl.)

Rong, Zhe, Li Li, Fei Fei, Lailong Luo, och Yang Qu. Retraction Note: Combined Treatment of Glibenclamide and CoCl2 Decreases MMP9 Expression and Inhibits Growth in Highly Metastatic Breast Cancer. BMC, 2025.

MLA-referens (9:e uppl.)

Rong, Zhe, et al. Retraction Note: Combined Treatment of Glibenclamide and CoCl2 Decreases MMP9 Expression and Inhibits Growth in Highly Metastatic Breast Cancer. BMC, 2025.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.